Decline in Big Pharma Deal Activity Mirrors Industry-wide Slowdown in Dealmaking

By Jawala Prasad & Jasmine Kalsi

Pharma Deals Review: Vol 2018 Issue 12 (Table of Contents)

Published: 28 Dec-2018

DOI: 10.3833/pdr.v2018.i12.2388     ISSN: 1756-7874

Section: Opinion & Analysis



Dealmaking is still an important and necessary means for companies to access innovation and sustain revenues in their therapeutic areas of focus...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details